£64.85

MDPI AG The Tumor Microenvironment of High Grade Serous Ovarian Cancer

Price data last checked 51 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£65 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 40 days • 40 data points (No recent data available)

Historical
Generating forecast...
£64.85 £61.61 £62.90 £64.20 £65.50 £66.80 £68.09 11 March 2026 20 March 2026 30 March 2026 09 April 2026 19 April 2026

Price Distribution

Price distribution over 40 days • 1 price levels

Days at Price
40 days 0 10 20 30 40 £65 Days at Price

Price Analysis

Most common price: £65 (40 days, 100.0%)

Price range: £65 - £65

Price levels: 1 different prices over 40 days

Description

The Special Issue on high grade serous ovarian cancer (HGSOC) and the contribution of the tumor microenviroment (TME) consists of reviews contributed by leaders in the OC field. As HGSOC metastases have a highly complex TME, there is an urgent need to better understand the TME in general, its distinct components in particular, and the role of the TME in the context of disease recurrence and development of chemoresistance. The Special Issue incorporates the current understanding of the different parts of thd TME components, including the cancer cells themselves, the cells surrounding the cancer cells or stromal cells, and the cells of the immune system, which are attracted to the site of metastases. In addition to these cells of the TME, the role of various cellular factors made by the cells of the TME are also the subject of the reviews. In addition, reviews in this Special Issue cover the complex relationships between the molecular mechanisms of HGSOC progression, including genomic, epigenomic and transcriptomic changes and changes in the immune cell landscape, as these may provide attractive new molecular targets for HGSOC therapy.

Product Specifications

Brand
MDPI AG
Format
paperback
Domain
Amazon UK
Release Date
04 February 2019
Listed Since
05 February 2019

Barcode

No barcode data available

Similar Products You Might Like

Advances in Diagnosis and Management of Ovarian Cancer
98% match

Advances in Diagnosis and Management of Ovarian Cancer

Springer

£119.99 01 Mar 2026
Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG)
98% match

Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG)

Springer

£87.83 08 Jan 2026
Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)
97% match

Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)

Springer

£92.56 06 Mar 2026
Ovarian Cancer Biomarkers: Mapping to Improve Outcomes
97% match

Ovarian Cancer Biomarkers: Mapping to Improve Outcomes

Springer

£80.65 06 Mar 2026
Ovarian Cancer: Methods and Protocols: 1049 (Methods in Molecular Biology, 1049)
97% match

Ovarian Cancer: Methods and Protocols: 1049 (Methods in Molecular Biology, 1049)

Humana

£79.50 15 Apr 2026
Encyclopedia of Ovarian Cancer
97% match

Encyclopedia of Ovarian Cancer

Hayle Medical

£68.50 11 Mar 2026
Ovarian Cancer: 23 (Cancer Treatment and Research, 23)
97% match

Ovarian Cancer: 23 (Cancer Treatment and Research, 23)

Springer

£106.06 24 Jan 2026
Ovarian Cancer: Second Edition: 149 (Cancer Treatment and Research, 149)
97% match

Ovarian Cancer: Second Edition: 149 (Cancer Treatment and Research, 149)

Springer

£80.09 09 Mar 2026
Clinical Trials in Ovarian Cancer
97% match

Clinical Trials in Ovarian Cancer

Rutgers University Press

£82.68 16 Feb 2026
Gynecologic Oncology: 95 (Cancer Treatment and Research, 95)
97% match

Gynecologic Oncology: 95 (Cancer Treatment and Research, 95)

Springer

£364.03 09 Jan 2026
Ovarian Cancer: Risks, Prevention and Management
97% match

Ovarian Cancer: Risks, Prevention and Management

Hayle Medical

£71.00 12 Apr 2026
Fundamentals in Gynaecologic Malignancy
96% match

Fundamentals in Gynaecologic Malignancy

£150.72 12 Jan 2026
Intraperitoneal Cancer Therapy (Current Clinical Oncology)
96% match

Intraperitoneal Cancer Therapy (Current Clinical Oncology)

Humana

£79.93 06 Mar 2026
Pathology of Female Cancers: Precursor and Early-Stage Breast, Ovarian and Uterine Carcinomas
96% match

Pathology of Female Cancers: Precursor and Early-Stage Breast, Ovarian and Uterine Carcinomas

Springer

£108.33 03 Apr 2026
Tumors of the Ovary and Fallopian Tube (AFIP Atlas of Tumor and Non-Tumor Pathology, Series 5, 16)
96% match

Tumors of the Ovary and Fallopian Tube (AFIP Atlas of Tumor and Non-Tumor Pathology, Series 5, 16)

American Registry of Pathology

£150.23 11 Feb 2026
Gynecologic Cancer Care: Innovative Progress (Volume 46-1) (The Clinics: Internal Medicine, Volume 46-1)
96% match

Gynecologic Cancer Care: Innovative Progress (Volume 46-1) (The Clinics: Internal Medicine, Volume 46-1)

Elsevier

£68.41 06 Mar 2026
Atlas of Clear Cell Carcinoma of the Ovary: A Pathological Guide
96% match

Atlas of Clear Cell Carcinoma of the Ovary: A Pathological Guide

Springer

£78.51 01 Mar 2026
Personalization in Gynecologic Oncology (Comprehensive Gynecology and Obstetrics)
96% match

Personalization in Gynecologic Oncology (Comprehensive Gynecology and Obstetrics)

Springer

£77.74 12 Apr 2026
Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)
96% match

Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)

Springer

£135.35 08 Mar 2026
DiSaia and Creasman Clinical Gynecologic Oncology
96% match

DiSaia and Creasman Clinical Gynecologic Oncology

Elsevier

£113.06 31 Jan 2026
Hereditary Gynecologic Cancer: Risk, Prevention and Management
96% match

Hereditary Gynecologic Cancer: Risk, Prevention and Management

CRC Press

£185.00 23 Jan 2026
Gynecological Cancer Management: Identification, Diagnosis and Treatment
96% match

Gynecological Cancer Management: Identification, Diagnosis and Treatment

Wiley-Blackwell

£76.78 08 Mar 2026
Ovarian Cancer Biomarkers: Mapping to Improve Outcomes
96% match

Ovarian Cancer Biomarkers: Mapping to Improve Outcomes

Springer

£103.30 02 Apr 2026
Atlas of Procedures in Gynecologic Oncology
96% match

Atlas of Procedures in Gynecologic Oncology

CRC Press

£197.48 24 Jan 2026